Related Experiment Videos
Effects of electroconvulsive therapy on plasma GABA
D P Devanand1, B Shapira, F Petty
1Department of Biological Psychiatry, College of Physicians and Surgeons of Columbia University, New York, NY, USA.
Convulsive Therapy
|March 1, 1995
Summary
Electroconvulsive therapy (ECT) acutely reduces plasma gamma-aminobutyric acid (GABA) levels in patients with major depression. Higher baseline GABA levels correlate with better ECT response, suggesting GABA function is linked to treatment outcomes.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Limited data exist on seizure effects on gamma-aminobutyric acid (GABA) function in humans.
- GABA is a key inhibitory neurotransmitter with implications for neurological and psychiatric disorders.
Purpose of the Study:
- To investigate the acute effects of electroconvulsive therapy (ECT) on free plasma GABA levels in major depressive disorder patients.
- To explore the relationship between baseline and post-ECT GABA levels and clinical response to ECT.
Main Methods:
- Study 1: Measured free plasma GABA in 39 major depressive disorder inpatients before and after ECT.
- Study 2: Compared real ECT versus sham ECT in 7 patients to assess replicability.
- Correlated GABA levels with ECT response status.
Main Results:
- Acutely after ECT, free plasma GABA levels were significantly reduced for up to 1 hour post-seizure in Study 1.
- Findings from Study 2 raised some questions about acute GABA reduction replicability.
- ECT responders exhibited higher baseline and post-ECT GABA levels compared to non-responders.
Conclusions:
- Free plasma GABA may be acutely reduced following ECT, a finding not consistently observed with other biochemical markers.
- The acute decrease in GABA might indicate reduced brain extracellular GABA or altered brain turnover.
- Higher baseline GABA levels in responders suggest that individuals with less abnormal GABA function may respond better to ECT, and low plasma GABA is not a state marker for depression.